Jonathan Jay Mazelsky - 07 Feb 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Issuer symbol
IDXX
Transactions as of
07 Feb 2024
Net transactions value
-$6,057,119
Form type
4
Filing time
09 Feb 2024, 17:00:48 UTC
Previous filing
16 Jan 2024
Next filing
16 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $814,200 +12,000 +15% $67.85 91,247 07 Feb 2024 Direct F1
transaction IDXX Common Stock Sale $3,062,061 -5,356 -5.9% $571.71 85,891 07 Feb 2024 Direct F2
transaction IDXX Common Stock Sale $2,361,094 -4,124 -4.8% $572.53 81,767 07 Feb 2024 Direct F3
transaction IDXX Common Stock Sale $264,814 -462 -0.57% $573.19 81,305 07 Feb 2024 Direct F4
transaction IDXX Common Stock Sale $777,639 -1,353 -1.7% $574.75 79,952 07 Feb 2024 Direct F5
transaction IDXX Common Stock Sale $405,711 -705 -0.88% $575.48 79,247 07 Feb 2024 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -12,000 -29% 29,260 07 Feb 2024 Common Stock 12,000 $67.85 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 13.247 shares purchased under the Issuer Employee Stock Purchase Plan on December 29, 2023.
F2 Represents the weighted average price of the shares sold ranging from a low of $571.12 to a high of $572.11 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average price of the shares sold ranging from a low of $572.13 to a high of $573.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Represents the weighted average price of the shares sold ranging from a low of $573.14 to a high of $573.23 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F5 Represents the weighted average price of the shares sold ranging from a low of $574.29 to a high of $575.19 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F6 Represents the weighted average price of the shares sold ranging from a low of $575.35 to a high of $575.65 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F7 Grant of option to buy shares of Issuer common stock that became exercisable in four annual installments beginning February 14, 2017.
F8 Not applicable.